From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational interest, as strategies aimed at restoring its mass could become therapies for glycemic dysregulation, drug-related diabetes following diabetogenic therapies, or hyperglycemic disturbances following the treatment of cancer and nesidioblastosis. Such strategies generally fall under one of the 'three Rs': replacement (islet transplantation and stem cell differentiation); reprogramming (e.g., from the exocrine compartment of the pancreas); and regeneration (replication and induction of endogenous stem cells). As the latter has been extensively reviewed in recent months by us and others, this article focuses on emerging reprogramming and replacement approaches.

Original languageEnglish
Pages (from-to)41-48
Number of pages8
JournalRegenerative Medicine
Volume7
Issue number6 SUPPL.
DOIs
StatePublished - Nov 1 2012

Fingerprint

Medical problems
Cell- and Tissue-Based Therapy
Tissue
Stem cells
Islets of Langerhans
Stem Cells
Nesidioblastosis
Exocrine Pancreas
Islets of Langerhans Transplantation
Type 2 Diabetes Mellitus
Regeneration
Cell Differentiation
Diabetes Mellitus
Therapeutics
Pharmaceutical Preparations
Neoplasms

Keywords

  • β-cell regeneration
  • β-cell replacement
  • β-cell reprogramming
  • diabetes
  • embryonic stem cell
  • induced pluripotent stem cell
  • islet transplantation
  • mesenchymal stem cell

ASJC Scopus subject areas

  • Biomedical Engineering
  • Embryology

Cite this

From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes. / Ricordi, Camillo; Inverardi, Luca A; Dominguez-Bendala, Juan.

In: Regenerative Medicine, Vol. 7, No. 6 SUPPL., 01.11.2012, p. 41-48.

Research output: Contribution to journalArticle

@article{251a955382b54b99a78b24e4371979fa,
title = "From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes",
abstract = "Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational interest, as strategies aimed at restoring its mass could become therapies for glycemic dysregulation, drug-related diabetes following diabetogenic therapies, or hyperglycemic disturbances following the treatment of cancer and nesidioblastosis. Such strategies generally fall under one of the 'three Rs': replacement (islet transplantation and stem cell differentiation); reprogramming (e.g., from the exocrine compartment of the pancreas); and regeneration (replication and induction of endogenous stem cells). As the latter has been extensively reviewed in recent months by us and others, this article focuses on emerging reprogramming and replacement approaches.",
keywords = "β-cell regeneration, β-cell replacement, β-cell reprogramming, diabetes, embryonic stem cell, induced pluripotent stem cell, islet transplantation, mesenchymal stem cell",
author = "Camillo Ricordi and Inverardi, {Luca A} and Juan Dominguez-Bendala",
year = "2012",
month = "11",
day = "1",
doi = "10.2217/rme.12.70",
language = "English",
volume = "7",
pages = "41--48",
journal = "Regenerative Medicine",
issn = "1746-0751",
publisher = "Future Medicine Ltd.",
number = "6 SUPPL.",

}

TY - JOUR

T1 - From cellular therapies to tissue reprogramming and regenerative strategies in the treatment of diabetes

AU - Ricordi, Camillo

AU - Inverardi, Luca A

AU - Dominguez-Bendala, Juan

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational interest, as strategies aimed at restoring its mass could become therapies for glycemic dysregulation, drug-related diabetes following diabetogenic therapies, or hyperglycemic disturbances following the treatment of cancer and nesidioblastosis. Such strategies generally fall under one of the 'three Rs': replacement (islet transplantation and stem cell differentiation); reprogramming (e.g., from the exocrine compartment of the pancreas); and regeneration (replication and induction of endogenous stem cells). As the latter has been extensively reviewed in recent months by us and others, this article focuses on emerging reprogramming and replacement approaches.

AB - Diabetes mellitus represents a global epidemic affecting over 350 million patients worldwide and projected by the WHO to surpass the 500 million patient mark within the next two decades. Besides Type 1 and Type 2 diabetes mellitus, the study of the endocrine compartment of the pancreas is of great translational interest, as strategies aimed at restoring its mass could become therapies for glycemic dysregulation, drug-related diabetes following diabetogenic therapies, or hyperglycemic disturbances following the treatment of cancer and nesidioblastosis. Such strategies generally fall under one of the 'three Rs': replacement (islet transplantation and stem cell differentiation); reprogramming (e.g., from the exocrine compartment of the pancreas); and regeneration (replication and induction of endogenous stem cells). As the latter has been extensively reviewed in recent months by us and others, this article focuses on emerging reprogramming and replacement approaches.

KW - β-cell regeneration

KW - β-cell replacement

KW - β-cell reprogramming

KW - diabetes

KW - embryonic stem cell

KW - induced pluripotent stem cell

KW - islet transplantation

KW - mesenchymal stem cell

UR - http://www.scopus.com/inward/record.url?scp=84870654705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870654705&partnerID=8YFLogxK

U2 - 10.2217/rme.12.70

DO - 10.2217/rme.12.70

M3 - Article

C2 - 23210810

AN - SCOPUS:84870654705

VL - 7

SP - 41

EP - 48

JO - Regenerative Medicine

JF - Regenerative Medicine

SN - 1746-0751

IS - 6 SUPPL.

ER -